Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
03/01/2023 | Eckelman Brendan P. | Chief Scientific Officer | Sale | Common Stock | 400 | $24.71 | $9.9k | By the Eckelman Living Trust dated February 5, 2014 | 03/01/2023 |
03/01/2023 | Eckelman Brendan P. | Chief Scientific Officer | Sale | Common Stock | 39.6k | $24.20 | $958.3k | By the Eckelman Living Trust dated February 5, 2014 | 03/01/2023 |
02/28/2023 | Lappe Mark | CEO | Sale | Common Stock | 60 | $25.02 | $1.5k | By the Lappe Family Trust | 02/28/2023 |
01/24/2023 | Lappe Mark | CEO | Sale | Common Stock | 4.3k | $25.71 | $109.8k | By the Lappe Family Trust | 01/23/2023 |
01/24/2023 | Lappe Mark | CEO | Sale | Common Stock | 63 | $26.11 | $1.6k | By the Lappe Family Trust | 01/23/2023 |
01/23/2023 | Lappe Mark | CEO | Sale | Common Stock | 21.7k | $25.36 | $549.4k | By the Lappe Family Trust | 01/23/2023 |
01/23/2023 | Kayyem Jon Faiz | Director | Sale | Common Stock | 9.5k | $25.26 | $240k | By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust | 01/23/2023 |
01/04/2023 | Eckelman Brendan P. | Chief Scientific Officer | Sale | Common Stock | 4.1k | $23.11 | $94.8k | By the Eckelman Living Trust dated February 5, 2014 | 01/03/2023 |
01/04/2023 | Eckelman Brendan P. | Chief Scientific Officer | Sale | Common Stock | 3k | $23.99 | $72k | By the Eckelman Living Trust dated February 5, 2014 | 01/03/2023 |
01/03/2023 | Eckelman Brendan P. | Chief Scientific Officer | Grant | Stock Option (right to buy) | 40k | $23.30 | $932k | | 01/03/2023 |
01/03/2023 | Eckelman Brendan P. | Chief Scientific Officer | Sale | Common Stock | 22.2k | $23.41 | $520.1k | By the Eckelman Living Trust dated February 5, 2014 | 01/03/2023 |
01/03/2023 | Eckelman Brendan P. | Chief Scientific Officer | Sale | Common Stock | 8.6k | $24.36 | $209.4k | By the Eckelman Living Trust dated February 5, 2014 | 01/03/2023 |
01/03/2023 | Eckelman Brendan P. | Chief Scientific Officer | Sale | Common Stock | 2.1k | $25.09 | $52.3k | By the Eckelman Living Trust dated February 5, 2014 | 01/03/2023 |
01/03/2023 | Lappe Mark | CEO | Grant | Stock Option (right to buy) | 100k | $23.30 | $2.3M | | 01/03/2023 |
01/03/2023 | Deck Kelly | CFO | Grant | Stock Option (right to buy) | 30k | $23.30 | $699k | | 01/03/2023 |
12/21/2022 | Kayyem Jon Faiz | Director | Sale | Common Stock | 2k | $27.61 | $54.1k | By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust | 12/21/2022 |
12/21/2022 | Kayyem Jon Faiz | Director | Sale | Common Stock | 7.5k | $26.87 | $202.6k | By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust | 12/21/2022 |
12/19/2022 | Lappe Mark | CEO | Sale | Common Stock | 25.2k | $25.53 | $644.6k | By the Lappe Family Trust | 12/19/2022 |
12/19/2022 | Lappe Mark | CEO | Sale | Common Stock | 754 | $26.29 | $19.8k | By the Lappe Family Trust | 12/19/2022 |
12/06/2022 | Eckelman Brendan P. | Chief Scientific Officer | Sale | Common Stock | 20.9k | $26.83 | $561.6k | By the Eckelman Living Trust dated February 5, 2014 | 12/06/2022 |
12/06/2022 | Eckelman Brendan P. | Chief Scientific Officer | Sale | Common Stock | 17.7k | $27.57 | $487.5k | By the Eckelman Living Trust dated February 5, 2014 | 12/06/2022 |
12/06/2022 | Eckelman Brendan P. | Chief Scientific Officer | Sale | Common Stock | 1.4k | $28.46 | $39.6k | By the Eckelman Living Trust dated February 5, 2014 | 12/06/2022 |
11/21/2022 | Kayyem Jon Faiz | Director | Sale | Common Stock | 2.7k | $29.33 | $80.2k | By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust | 11/21/2022 |
11/21/2022 | Kayyem Jon Faiz | Director | Sale | Common Stock | 6.8k | $30.12 | $203.8k | By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust | 11/21/2022 |
11/17/2022 | Lappe Mark | CEO | Sale | Common Stock | 7k | $25.36 | $176.5k | By the Lappe Family Trust | 11/17/2022 |
11/17/2022 | Lappe Mark | CEO | Sale | Common Stock | 4.1k | $26.57 | $109.1k | By the Lappe Family Trust | 11/17/2022 |
11/17/2022 | Lappe Mark | CEO | Sale | Common Stock | 4.3k | $27.45 | $118.9k | By the Lappe Family Trust | 11/17/2022 |
11/17/2022 | Lappe Mark | CEO | Sale | Common Stock | 1.8k | $28.86 | $51k | By the Lappe Family Trust | 11/17/2022 |
11/17/2022 | Lappe Mark | CEO | Sale | Common Stock | 6.8k | $30.15 | $204.2k | By the Lappe Family Trust | 11/17/2022 |
11/17/2022 | Lappe Mark | CEO | Sale | Common Stock | 912 | $30.67 | $28k | By the Lappe Family Trust | 11/17/2022 |
11/17/2022 | Lappe Mark | CEO | Sale | Common Stock | 1.2k | $32.38 | $37.2k | By the Lappe Family Trust | 11/17/2022 |
11/01/2022 | Eckelman Brendan P. | Chief Scientific Officer | Sale | Common Stock | 27.7k | $33.34 | $921.7k | By the Eckelman Living Trust dated February 5, 2014 | 11/01/2022 |
11/01/2022 | Eckelman Brendan P. | Chief Scientific Officer | Sale | Common Stock | 12.3k | $33.90 | $418.6k | By the Eckelman Living Trust dated February 5, 2014 | 11/01/2022 |
10/17/2022 | Lappe Mark | CEO | Sale | Common Stock | 121 | $31.51 | $3.8k | By the Lappe Family Trust | 10/17/2022 |
10/17/2022 | Lappe Mark | CEO | Sale | Common Stock | 9k | $28.66 | $257.4k | By the Lappe Family Trust | 10/17/2022 |
|